Cogent Biosciences, Inc. (COGT) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Cogent Biosciences, Inc. (COGT) closed at USD 29.51 on 2026-10-15, a change of +84.4 % over the past year, with a market capitalization of USD 5.12B.

Cogent Biosciences, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Cogent Biosciences, Inc. key figures

Previous close

USD 29.51 (2026-10-15)

1-year change

+84.4 %

Market cap

USD 5.12B

Enterprise value

USD 4.64B

P/E ratio (trailing)

-13.67

P/E ratio (forward)

-26.55

EPS (trailing)

-2.16

EPS (forward)

-1.11

PEG ratio

n/a

Price to book

10.84

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

9.63

Employees

258

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Cogent Biosciences, Inc.

Cogent Biosciences, Inc., a clinical-stage biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor in Phase 3 trial designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company also develops CGT4859, a reversible and selective fibroblast growth factor receptor 2 inhibitor in Phase 1 trial for patients with documented FGFR mutations, including advanced cholangiocarcinoma; CGT4255, a novel ErbB2 mutant program, which is focused on actionable and underserved mutations in a solid tumor systemic and CNS involved indications; and CGT6297, a Novel PI3Ka mutant-selective inhibitor. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. Cogent Biosciences, Inc. is headquartered in Waltham, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Cogent Biosciences, Inc. and compare it with other stocks.